A Clinical Trial of Three Study Medicines (Encorafenib, Binimetinib, and Pembrolizumab) in Patients With Advanced or Metastatic Melanoma
Pfizer
Pfizer
H. Lee Moffitt Cancer Center and Research Institute
Novartis
Merck Sharp & Dohme LLC
H. Lee Moffitt Cancer Center and Research Institute
University of Southern California
DEKA Biosciences
Regeneron Pharmaceuticals